MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Peripheral artery disease (PAD) is a disease of atherosclerosis in the lower extremities. PAD carries a massive burden worldwide, while diagnosis and treatment options are often lacking. One of the key points of research in recent years is the involvement of microRNAs (miRNAs), which are short 20-25 nucleotide single-stranded RNAs that can act as negative regulators of post-transcriptional gene expression. Many of these miRNAs have been discovered to be misregulated in PAD patients, suggesting a potential utility as biomarkers for PAD diagnosis. miRNAs have also been shown to play an important role in many different pathophysiological aspects involved in the initiation and progression of the disease including angiogenesis, hypoxia, inflammation, as well as other cellular functions like cell proliferation and migration. The research on miRNAs in PAD has the potential to lead to a whole new class of diagnostic tools and treatments.

Cite

CITATION STYLE

APA

Ring, A., Ismaeel, A., Wechsler, M., Fletcher, E., Papoutsi, E., Miserlis, D., & Koutakis, P. (2022). MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms. Therapeutic Advances in Cardiovascular Disease. SAGE Publications Ltd. https://doi.org/10.1177/17539447221096940

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free